Jay Venkatesan Angion Biomedica Corp. (ANGN) insider trading activity

Jay Venkatesan is Director of Angion Biomedica Corp.. Currently has a direct ownership of 179,581 shares of ANGN, which is worth approximately $0. The most recent transaction as insider was on Nov 26, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.01 per share, resulting in proceeds of $500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 180K

90.51% 3M change

90.51% 12M change

Total Value Held $0

Jay Venkatesan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 26 2024	BUY Exercise of in-the-money or at-the-money derivatives securities	$500 $0.01 p/Share	50,000 Added 21.78%	179,581 Common Stock
May 25 2022	BUY Open market or private purchase	$14,141 $1.25 p/Share	11,313 Added 0.59%	1,891,947 Common Stock
May 24 2022	BUY Open market or private purchase	$39,928 $1.24 p/Share	32,200 Added 1.84%	1,721,457 Common Stock
May 20 2022	BUY Open market or private purchase	$61,500 $1.23 p/Share	50,000 Added 2.87%	1,689,257 Common Stock
Dec 28 2021	BUY Open market or private purchase	$559,496 $2.66 p/Share	210,337 Added 11.37%	1,639,257 Common Stock
Dec 27 2021	BUY Open market or private purchase	$170,613 $2.55 p/Share	66,907 Added 4.47%	1,428,920 Common Stock
Dec 20 2021	BUY Open market or private purchase	$8,959 $2.54 p/Share	3,527 Added 0.26%	1,362,013 Common Stock
Dec 17 2021	BUY Open market or private purchase	$34,905 $2.54 p/Share	13,742 Added 1.0%	1,358,486 Common Stock
Dec 16 2021	BUY Open market or private purchase	$71,102 $2.55 p/Share	27,883 Added 2.03%	1,344,744 Common Stock
Dec 15 2021	BUY Open market or private purchase	$187,026 $2.41 p/Share	77,604 Added 5.57%	1,316,861 Common Stock
Jun 24 2021	SELL Payment of exercise price or tax liability	$566,234 $13.78 p/Share	41,091 Reduced 3.21%	1,239,257 Common Stock
Feb 09 2021	SELL Open market or private sale	$2,546,832 $16.0 p/Share	159,177 Reduced 11.64%	1,208,086 Common Stock
Feb 09 2021	SELL Payment of exercise price or tax liability	$511,456 $16.0 p/Share	31,966 Reduced 2.99%	1,037,017 Common Stock
Feb 09 2021	BUY Conversion of derivative security	$1,913,169 $11.57 p/Share	165,356 Added 11.44%	1,280,348 Common Stock
Feb 09 2021	BUY Exercise of in-the-money or at-the-money derivatives securities	$1,524,887 $6.43 p/Share	237,152 Added 14.15%	1,439,263 Common Stock

Also insider at

ALPN

ALPINE IMMUNE SCIENCES, INC. Healthcare

Director

Jay Venkatesan

Director

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANGN shares.

Notify only if

Value

Insider Trading

Get notified when an Angion Biomedica Corp. insider buys or sells ANGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Angion Biomedica Corp.

Track Activities on ANGN

Account